Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Medumo
AddedMar 17, 2024
UpdatedJul 3, 2026
Medumo

Medumo

Acquired

Transforming care delivery with automated patient instructions for hospitals. Contact us to get started!

Accelerator
Y Combinator logoY CombinatorW18
Overview
Compare
Fundraising
Employees

Medumo's mission is to transform care delivery by managing patient instructions for hospitals through automated, precisely-timed messages sent via text and email. Their core product, CareTours™, provides turn-by-turn guidance to patients, improving procedural completion rates, increasing referral conversions, reducing staff burden, and recovering revenue loss. The team comprises Harvard and Yale-trained physicians, engineers, designers, and social entrepreneurs.

Medumo has significantly impacted healthcare organizations by enhancing patient compliance and operational efficiency. Their innovative approach has led to dramatic improvements in procedural completion rates and reduced staff workload. The company's solutions have been instrumental in recovering lost revenue for hospitals, showcasing their effectiveness in the healthcare market.

Medumo - Similar Companies

Bot MD logo

Bot MD

botmd.io

Medigram logo

Medigram

medigram.com

MedAux logo

MedAux

MedThread logo

MedThread

medthread.com

Gradia Health logo

Gradia Health

gradia.com

Medifies logo

Medifies

medifies.com

Medmo logo

Medmo

medmo.com

CareMessage logo

CareMessage

caremessage.org

AgileMD logo

AgileMD

agilemd.com

Mednet logo

Mednet

themednet.org

Mederva Health logo

Mederva Health

medervahealth.com

MedMe Health logo

MedMe Health

medmehealth.com

Health Note logo

Health Note

healthnote.com

Shift Health logo

Shift Health

shifthealth.io

Clarion logo

Clarion

clarionhealth.com

Medumo - Quick Facts

Who are Medumo's competitors?

Companies similar to Medumo include Bot MD, Medigram, MedAux and MedThread.

When was Medumo's last funding round?

Medumo's most recent funding round was for $120k (USD) in January 2018.

How much has Medumo raised to-date?

As of Jan 1, 2018, Medumo has raised a total of $120k (USD).

Medumo - Classification

Industry
  • Professional Service Companies
Ownership
  • Venture Capital
Technology
  • AI
  • Automation
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Patient Instructions
Tags
  • Consulting
  • Healthtech
  • SaaS